Fig. 2From: WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemiaBoth WT1 vaccine in Montanide and poly ICLC could decrease WT1 level during the vaccination; and WT1 level is correlated with disease progressionBack to article page